These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 37454068

  • 21. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.
    Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, Jourdain G, Moreau A, Borkird T, Layangool P, Kamonpakorn N, Jitphiankha W, Kwanchaipanich R, Potchalongsin S, Lallemant M, Sirirungsi W, Goudeau A, Program for HIV Prevention and Treatment (PHPT) group.
    J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828
    [Abstract] [Full Text] [Related]

  • 22. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G, Pumei D, Jianhui Y, Jin X, Yanyang Z, Zhe W.
    J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y, Song Y, Zhai X, Zhu F, Liu J, Chang Z, Li Y, Xiao Y, Li L, Liu M, Liu J, Duan Z, Zou H, Zhuang H, Wang J, Li J.
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [Abstract] [Full Text] [Related]

  • 25. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV.
    Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, Huang FC, Wu SF, Chen SC, Wen WH, Chu CH, Ni YH, Hsu HY, Tsai PL, Chiang CL, Shyu MK, Lee PI, Chang FY, Chang MH.
    Gastroenterology; 2012 Apr; 142(4):773-781.e2. PubMed ID: 22198276
    [Abstract] [Full Text] [Related]

  • 26. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX.
    J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
    [Abstract] [Full Text] [Related]

  • 27. Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
    Chen T, Wang J, Feng Y, Yan Z, Zhang T, Liu M, Bai Y, Song H, Liu H, Yang Y, Liu J, He Y, Chen Y, Zhang S, Zhuang G, Liang X, Liu Z, Xu X, Chen W, Liu Y, Zhao Y.
    BMC Infect Dis; 2013 Nov 06; 13():524. PubMed ID: 24195671
    [Abstract] [Full Text] [Related]

  • 28. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants.
    Pan CQ, Zou HB, Chen Y, Zhang X, Zhang H, Li J, Duan Z.
    Clin Gastroenterol Hepatol; 2013 Oct 06; 11(10):1349-55. PubMed ID: 23639606
    [Abstract] [Full Text] [Related]

  • 29. Quantitative Hepatitis B Surface Antigen Predicts Hepatitis B Transmission in Infants Born to e Antigen-positive Mothers.
    Peng S, Wan Z, Liu T, Wang Y, Chen H, Li X, Du Y.
    J Clin Gastroenterol; 2020 Jan 06; 54(1):76-82. PubMed ID: 30575631
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH, Chen DS.
    Pathol Biol (Paris); 2010 Aug 06; 58(4):296-300. PubMed ID: 20116181
    [Abstract] [Full Text] [Related]

  • 31. The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus.
    Chang MH, Hsu HY, Huang LM, Lee PI, Lin HH, Lee CY.
    J Hepatol; 1996 Jun 06; 24(6):674-9. PubMed ID: 8835741
    [Abstract] [Full Text] [Related]

  • 32. Perinatal transmission of hepatitis B virus: an Australian experience.
    Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT.
    Med J Aust; 2009 May 04; 190(9):489-92. PubMed ID: 19413519
    [Abstract] [Full Text] [Related]

  • 33. Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus.
    Huang H, Xu C, Liu L, Chen L, Zhu X, Chen J, Feng J, Chen T, Xu B, Yang J, Xu B, Pan M, Dai Y, Hu Y, Zhou YH.
    Clin Infect Dis; 2021 Nov 02; 73(9):e3317-e3323. PubMed ID: 32634824
    [Abstract] [Full Text] [Related]

  • 34. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
    van Schalkwyk J, Nourmoussavi M, Massey A, Gustafson R, Brodkin E, Petric M, Krajden M, Dobson S, Buxton J, Bigham M, Pick N, Schreiber R, Sherlock CH, Money D, Yoshida EM.
    Can J Gastroenterol Hepatol; 2014 Nov 02; 28(10):525-8. PubMed ID: 25390612
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto Nigeria.
    Erhabor O, Mohammad SY, Bello L, Onuigwe FU, Abdulrahman Y, Zama I, Buhari H, Bagudo A, Ibrahim K, Ahmed M, Udomah FP, Adias TC, Erhabor T, Okara GC.
    Hum Antibodies; 2020 Nov 02; 28(3):233-243. PubMed ID: 32333583
    [Abstract] [Full Text] [Related]

  • 36. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N.
    N Engl J Med; 2018 Mar 08; 378(10):911-923. PubMed ID: 29514030
    [Abstract] [Full Text] [Related]

  • 37. Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study.
    Gu J, Xu Y, Yuan J, Chen Y, Luo J, Guo C, Zhang G.
    JMIR Public Health Surveill; 2024 Sep 04; 10():e60021. PubMed ID: 39230944
    [Abstract] [Full Text] [Related]

  • 38. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers.
    Cao M, Wu Y, Wen S, Pan Y, Wang C, Zhang X, Kong F, Lu Y, Wang C, Niu J, Li J, Jiang J.
    Infect Genet Evol; 2018 Sep 04; 63():243-248. PubMed ID: 29883771
    [Abstract] [Full Text] [Related]

  • 39. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers.
    Zou H, Chen Y, Duan Z, Zhang H, Pan C.
    J Viral Hepat; 2012 Feb 04; 19(2):e18-25. PubMed ID: 22239517
    [Abstract] [Full Text] [Related]

  • 40. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region.
    Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, Jacquet JM.
    J Viral Hepat; 2011 May 04; 18(5):369-75. PubMed ID: 20384962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.